Influenza mitigation recommendations, symptoms, and viral RNA shedding durations-2023-24 and 2024-25 seasons.

Authors

Elizabeth B White, Caroline A O'Neil, Melissa S Stockwell, Son H McLaren, Ellen Sano, Celibell Y Vargas, Henry C Fremont, Stacey House, Rachel M Presti, Stephanie A Fritz, Carlos G Grijalva, H Keipp Talbot, Jonathan E Schmitz, Yuwei Zhu, Theresa A Scott, Sydney A Cornelison, Jessica E Biddle, Emily A McNair, Samantha G Dean, Lydia Bristol, Alexandra M Mellis, Jennie H Kwon

Published in

American journal of epidemiology. Sep 10, 2026. Epub Sep 10, 2026.

Abstract

In March 2024, CDC released symptom-based isolation guidance for viral respiratory illnesses including influenza: isolation from others until fever-free for 24 hours and other symptoms are improving, followed by 5 days of post-isolation precautions. This study evaluated how well these recommendations aligned with influenza virus RNA shedding and assessed self-reported isolation in a multi-site household study during 2023-2025. We analyzed data from 1294 participants with influenza, including 627 with a clear peak in viral RNA levels and symptom resolution during follow-up. Participants provided daily symptom diaries and nasal swabs. We used Kaplan-Meier models to estimate recommended isolation duration based on CDC guidelines and compared this to viral RNA shedding measured by cycle threshold values and viral loads. The median recommended isolation duration was 6 days (interquartile range 4-7). Peak viral RNA shedding occurred a median of 4 days post-symptom onset, falling during recommended isolation for 80% (by Ct) and 69% (by viral load) of participants and increasing to 100% and 97% respectively by day 6 post-isolation. However, only 21% reported isolating from household members (median 2 days), and 80% isolated from the community (median 4 days). These findings support symptom-based isolation and emphasize the importance of post-isolation precautions.

PMID:
42720580
Bibliographic data and abstract were imported from PubMed on 10 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.